A detailed history of New York State Common Retirement Fund transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,220,257 shares of IOVA stock, worth $9.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,220,257
Previous 1,208,867 0.94%
Holding current value
$9.1 Million
Previous $9.7 Million 18.18%
% of portfolio
0.02%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$7.28 - $11.9 $82,919 - $135,541
11,390 Added 0.94%
1,220,257 $11.5 Million
Q2 2024

Jul 31, 2024

BUY
$7.78 - $14.19 $343,354 - $626,247
44,133 Added 3.79%
1,208,867 $9.7 Million
Q1 2024

May 07, 2024

BUY
$7.59 - $17.47 $1.08 Million - $2.5 Million
142,910 Added 13.99%
1,164,734 $17.3 Million
Q4 2023

Feb 01, 2024

SELL
$3.3 - $8.89 $16,965 - $45,703
-5,141 Reduced 0.5%
1,021,824 $8.31 Million
Q3 2023

Nov 07, 2023

BUY
$4.44 - $8.79 $850,131 - $1.68 Million
191,471 Added 22.92%
1,026,965 $4.67 Million
Q2 2023

Aug 07, 2023

BUY
$5.36 - $9.06 $847,871 - $1.43 Million
158,185 Added 23.35%
835,494 $5.88 Million
Q1 2023

May 02, 2023

BUY
$5.53 - $8.22 $474,396 - $705,160
85,786 Added 14.5%
677,309 $4.14 Million
Q4 2022

Jan 30, 2023

BUY
$5.62 - $10.0 $151,897 - $270,280
27,028 Added 4.79%
591,523 $3.78 Million
Q3 2022

Nov 08, 2022

BUY
$9.53 - $13.11 $92,155 - $126,773
9,670 Added 1.74%
564,495 $5.41 Million
Q2 2022

Aug 04, 2022

BUY
$6.38 - $18.33 $211,407 - $607,382
33,136 Added 6.35%
554,825 $6.13 Million
Q4 2021

Feb 02, 2022

SELL
$16.55 - $27.63 $1.82 Million - $3.04 Million
-109,864 Reduced 17.4%
521,689 $9.96 Million
Q3 2021

Nov 02, 2021

SELL
$20.35 - $26.63 $441,147 - $577,285
-21,678 Reduced 3.32%
631,553 $15.6 Million
Q2 2021

Aug 02, 2021

BUY
$16.33 - $33.07 $182,879 - $370,350
11,199 Added 1.74%
653,231 $17 Million
Q1 2021

May 11, 2021

SELL
$28.67 - $52.59 $1.09 Million - $2 Million
-38,119 Reduced 5.6%
642,032 $20.3 Million
Q4 2020

Feb 08, 2021

SELL
$28.04 - $50.26 $514,786 - $922,723
-18,359 Reduced 2.63%
680,151 $31.6 Million
Q3 2020

Nov 05, 2020

BUY
$27.75 - $36.3 $158,619 - $207,490
5,716 Added 0.83%
698,510 $23 Million
Q2 2020

Aug 07, 2020

BUY
$27.21 - $41.0 $6.58 Million - $9.91 Million
241,653 Added 53.56%
692,794 $19 Million
Q1 2020

May 06, 2020

BUY
$19.54 - $38.85 $652,675 - $1.3 Million
33,402 Added 8.0%
451,141 $13.5 Million
Q4 2019

Feb 05, 2020

BUY
$17.95 - $29.41 $1.12 Million - $1.84 Million
62,601 Added 17.63%
417,739 $11.6 Million
Q3 2019

Nov 07, 2019

BUY
$17.99 - $26.0 $499,582 - $722,020
27,770 Added 8.48%
355,138 $6.46 Million
Q2 2019

Aug 09, 2019

BUY
$9.78 - $24.52 $2.27 Million - $5.69 Million
231,968 Added 243.15%
327,368 $8.03 Million
Q1 2019

May 08, 2019

BUY
$8.41 - $11.26 $124,468 - $166,648
14,800 Added 18.36%
95,400 $907,000
Q4 2018

Feb 08, 2019

SELL
$7.51 - $11.93 $81,108 - $128,844
-10,800 Reduced 11.82%
80,600 $713,000
Q2 2018

Aug 10, 2018

BUY
$12.45 - $16.95 $159,360 - $216,960
12,800 Added 16.28%
91,400 $1.17 Million
Q1 2018

May 10, 2018

BUY
$8.1 - $19.5 $223,560 - $538,200
27,600 Added 54.12%
78,600 $1.33 Million
Q2 2017

Aug 11, 2017

BUY
N/A
51,000
51,000 $375,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.18B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.